Navigation Links Updates Outlook on Biotech Stocks

PRINCETON, N.J., March 12 /PRNewswire-FirstCall/ -- (, an online investment newsletter focused on long-term growth and income-generating stocks, has provided subscribers with updated coverage of several biotech stocks, including Amgen (Nasdaq: AMGN), Gilead Sciences (Nasdaq: GILD), Celgene (Nasdaq: CELG), Genzyme (Nasdaq: GENZ), and Vertex Pharmaceuticals (Nasdaq: VRTX).

All paid and trial subscribers to can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our Recommended List of stocks, which outperformed the S&P 500 by 15% in 2008.

Start your 14-day free trial today:

In its daily report, wrote: "The Pfizer-Wyeth combo, followed quickly by the Merck-Schering announcement, laid waste to the notion that Big Pharma was coveting successful biotechs. (It is, we suppose, another example of why investors should cover their ears when they hear 'conventional wisdom' and 'Wall Street' in the same sentence.) Granted, Europe's Roche Holdings today bought the portion of Genentech that it doesn't already own, but in this case, the two companies have a long-standing relationship and the latter made sure it extracted the highest possible price." looked at the following topics, among others:

-- What drug candidate could turn Amgen back into a growth story in 2010?

-- Why does Vertex's recent purchase of ViroChemPharma look like a smart move?

-- How does Celgene's principal drug Revlimid have an advantage over other multiple myeloma treatments?

-- What event has been a real black eye for Genzyme?

-- What recent event demonstrates that it will be difficult for generic drug companies to produce generic versions of biologics?

-- Is now the time to buy biotech stocks, and which ones look the most promising?


Launched in 1997, has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.


Marcie Martin, Bull Market Report, +1-888-278-5515

SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Examines Stem Cell Stocks
2. Examines Healthcare IT Stocks
3. Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
4. Cell Therapeutics Updates Shareholders on Trading
5. Service Corporation International Updates Fourth Quarter 2008 Guidance
6. NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
7. LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
8. Medical Management Corporation Updates Medical Billing Services
9. Omnicell Updates 2008 Year End Guidance and Announces Company Reorganization
10. LegalView Updates Peanut Butter Recall Information Portal with Info on Salmonella Contaminations Among Several Tainted Food Products
11. CEO of Traxxec, Inc. updates on Intellectual Property
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... December 01, 2015 , ... TCS Healthcare Technologies (TCS), ... population health arenas, is pleased to announce that VIP Care Services, a Caprock ... implemented the ACUITY Complete Care™ Management to back their collaborative catastrophic case management ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , a leader ... leadership since 2008. Gary Bruce, President of PartnerTech North America, currently serves as ... significant amount of time in Sweden since joining PartnerTech based in Malmo, Sweden. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash ... Modern Man for 2015. , Angeleno Magazine is a division of Modern ... in 1994, Modern Luxury includes more than 50 magazine titles across 15 major ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... addition of the "Veterinary Equipment and Disposables ... to 2020" report to their offering. ... of the "Veterinary Equipment and Disposables Market ... 2020" report to their offering. --> ...
(Date:12/1/2015)... , Dec. 1, 2015   MabVax Therapeutics Holdings, ... company, announces it has filed an Investigational New Drug ... (FDA) for the Company,s lead fully human antibody product ... acceptance, MabVax plans to initiate the Phase I clinical ... --> The planned Phase I trial ...
Breaking Medicine Technology: